メタ情報
| meta description平均長 | 4 |
|---|
| OGPありページ数 | 0 |
|---|
| Twitterカードありページ数 | 0 |
|---|
内部リンク分析（Internal）
| ユニーク内部リンク数 | 112 |
|---|
| ページあたり内部リンク平均 | 35.55 |
|---|
連絡先候補（Contacts）
このデータの閲覧には会員登録が必要になります。会員登録
キーワード分析（KeywordMap）
ワードクラウド上位
| 語 | 重み |
|---|
| van | 1 |
| Bisphenol | 0.837114 |
| model | 0.727273 |
| Clinical | 0.727273 |
| Drug | 0.636364 |
| Metabolism | 0.556479 |
| Brain | 0.538145 |
| 14C | 0.497844 |
| mice | 0.481866 |
| health | 0.454545 |
| Food | 0.454545 |
| EFSA | 0.454545 |
| Microbiome | 0.454545 |
| drug | 0.444799 |
| Regulation | 0.444799 |
| Pharmacology | 0.444799 |
| vitro | 0.444799 |
| fibrosis | 0.444799 |
| possible | 0.418557 |
| presence | 0.418557 |
| Clearance | 0.418557 |
| study | 0.409091 |
| Poster | 0.409091 |
| Pharmacokinetics | 0.409091 |
| vivo | 0.404498 |
| human | 0.373383 |
| AMS | 0.373383 |
| Evaluation | 0.370666 |
| Mass | 0.370666 |
| analysis | 0.363636 |
| Materials | 0.363636 |
| Hepatic | 0.363636 |
| FCM | 0.363636 |
| Steeg | 0.363636 |
| Biliary | 0.358763 |
| Microtracer | 0.358763 |
| muscle | 0.358763 |
| gut | 0.344487 |
| Link | 0.344487 |
| MASH | 0.342268 |
| Human | 0.342268 |
| induced | 0.342268 |
| Leiden | 0.333599 |
| NASH | 0.333599 |
| Disposition | 0.333599 |
| microbiota | 0.318182 |
| Study | 0.318182 |
| intestinal | 0.318182 |
| Evita | 0.318182 |
| Phase | 0.318182 |
共起語上位
| 語1 | 語2 | スコア | 共起ページ数 |
|---|
| Clinical | Pharmacology | 3.075918 | 44 |
| health | possible | 2.826267 | 27 |
| Evaluation | possible | 2.6994 | 26 |
| Frank | Schuren | 2.612991 | 16 |
| Recent | paper | 2.612676 | 20 |
| Disposition | Metabolism | 2.612668 | 37 |
| articles | materials | 2.608046 | 18 |
| Steeg | van | 2.564461 | 33 |
| Evaluation | health | 2.528031 | 26 |
| Lipogenesis | Novo | 2.50288 | 16 |
| Sex | differences | 2.456578 | 13 |
| Evita | Steeg | 2.43822 | 21 |
| Evita | van | 2.414198 | 29 |
| metabolite | microbial | 2.375092 | 12 |
| demonstrates | intestine | 2.375092 | 12 |
| beneficial | demonstrates | 2.375092 | 12 |
| Esmee | Wierenga | 2.375092 | 12 |
| Radonjic | Wielinga | 2.375092 | 12 |
| Kleemann | Ommen | 2.375092 | 12 |
| FCM | 食品接触材料 | 2.372339 | 17 |
| health | risks | 2.361314 | 20 |
| Oct | accessed | 2.336847 | 16 |
| Pharmacology | Therapeutics | 2.315312 | 20 |
| Drug | Metabolism | 2.303401 | 47 |
| Mass | Spectrometry | 2.279577 | 17 |
| cognition | tests | 2.252708 | 12 |
| host | microbial | 2.252708 | 12 |
| interaction | metabolite | 2.252708 | 12 |
| Donkers | Joanne | 2.252708 | 12 |
| CKD | DKD | 2.252708 | 12 |
| C2C12 | cells | 2.252708 | 12 |
| Kelder | Wielinga | 2.232889 | 11 |
| field | per | 2.225776 | 9 |
| associated | risks | 2.212835 | 16 |
| Ldlr | Leiden | 2.212835 | 16 |
| Accelerator | Mass | 2.180988 | 16 |
| Balance | Mass | 2.180988 | 16 |
| Machine | Normothermic | 2.157779 | 12 |
| Machine | Perfusion | 2.157779 | 12 |
| beneficial | effects | 2.157779 | 12 |
| Ducares | Triskelion | 2.152144 | 12 |
| biology | systems | 2.130323 | 12 |
| Accelerator | Spectrometry | 2.130323 | 12 |
| inulin | upon | 2.130323 | 12 |
| Specific | directive | 2.116788 | 8 |
| Food | Materials | 2.091618 | 20 |
| watch | webinar | 2.080811 | 8 |
| aging | muscle | 2.077008 | 13 |
| Biliary | Clearance | 2.070877 | 16 |
| long | term | 2.044834 | 8 |